Clinical Trial: An Open-label Study of HS-20137 in Participants With Moderate-to-Severe Plaque Psoriasis

U.S., Oct. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07879885) titled 'An Open-label Study of HS-20137 in Participants With Moderate-to-Severe Plaque Psoriasis' on Oct. 11.

Brief Summary: The purpose of this study is to evaluate the safety and efficacy of HS-20137 in the treatment of participants with moderate-to-severe plaque psoriasis

Study Start Date: July 31, 2025

Study Type: INTERVENTIONAL

Condition: Moderate-to-severe Plaque Psoriasis

Intervention: BIOLOGICAL: HS-20137

HS-20137 200 mg injection at weeks 0, 4 and 8

Recruitment Status: RECRUITING

Sponsor: Hansoh BioMedical R&D Company

Disclaimer: Curated by HT Syndication....